Pimavanserin (Nuplazid) for Parkinson's disease psychosis

MeSH terms

• Antiparkinson Agents / administration & dosage
• Antiparkinson Agents / adverse effects
• Antiparkinson Agents / economics
• Antiparkinson Agents / therapeutic use*
• Antipsychotic Agents / administration & dosage
• Antipsychotic Agents / adverse effects
• Antipsychotic Agents / economics
• Antipsychotic Agents / therapeutic use*
• Drug Administration Schedule
• Drug Costs
• Drug Interactions
• Humans
• Parkinson Disease / diagnosis
• Parkinson Disease / drug therapy*
• Parkinson Disease / economics
• Parkinson Disease / psychology
• Piperidines / administration & dosage
• Piperidines / adverse effects
• Piperidines / economics
• Piperidines / therapeutic use*
• Psychotic Disorders / diagnosis
• Psychotic Disorders / drug therapy*
• Psychotic Disorders / economics
• Psychotic Disorders / psychology
• Treatment Outcome
• Urea / administration & dosage
• Urea / adverse effects
• Urea / analogs & derivatives*
• Urea / economics
• Urea / therapeutic use